Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

26.2%

% of BBP's 65 holdings also in SBIO

18.0%

% of SBIO's 89 holdings also in BBP

Overlap by Weight
Sector Drift (BBP minus SBIO)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in SBIO
Overlap
ACADIA PHARMACEUTICALS INC 1.9% 2.1% 1.9%
KRYSTAL BIOTECH, INC. 1.7% 3.4% 1.7%
AGIOS PHARMACEUTICALS INC 1.5% 1.6% 1.5%
MIRUM PHARMACEUTICALS, INC. 2.4% 1.5% 1.5%
AMICUS THERAPEUTICS INC 1.4% 2.0% 1.4%

Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to SBIO
ALNYLAM PHARMACEUTICALS INC 2.1%
TRAVERE THERAPEUTICS, INC. 2.0%
LIGAND PHARMACEUTICALS-CL B 1.9%
LEXICON PHARMACEUTICALS, INC. 1.9%
LEGEND BIOTECH CORPORATION SPONSORED 1.9%
IONIS PHARMACEUTICALS, INC. 1.8%
TG THERAPEUTICS INC 1.8%
ADMA BIOLOGICS, INC. 1.8%
INSMED INC 1.8%
GILEAD SCIENCES INC 1.8%
BBP Underweight Relative to SBIO
CORCEPT THERAPEUTICS INC -4.2%
ALKERMES PLC -3.6%
ARCELLX, INC. -3.2%
CRINETICS PHARMACEUTICALS INC -3.1%
AVIDITY BIOSCIENCES INC -2.7%
DENALI THERAPEUTICS INC. -2.3%
MERUS N.V. -2.2%
MOONLAKE IMMUNOTHERAPEUTICS CLASS A -2.1%
VERICEL CORPORATION -2.0%
VERA THERAPEUTICS, INC. CLASS A -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY